checkAd
    Startseite > Aktien > Gossamer Bio > Nachrichten
    Gossamer Bio Aktie
    0,5065
     
    EUR
    +0,40 %
    +0,0020 EUR
    Letzter Kurs 15:49:41 Tradegate
    0,4744
     
    EUR
    6.330 STK
    Geldkurs 18:51:26
    0,4858
     
    EUR
    6.180 STK
    Briefkurs 18:51:26
    ISIN: US38341P1021 · WKN: A2PCBS · SYM: 4GB · USA

    Neueste Nachrichten

    Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    07.06.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
    14.05.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    10.05.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
    07.05.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
    06.05.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
    03.05.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
    12.03.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
    05.03.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    08.01.24 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023
    13.12.23 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    05.12.23 · Business Wire (engl.) · Gossamer Bio
    Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
    05.12.23 · Business Wire (engl.) · Gossamer Bio